iBio, Inc.
NASDAQ:IBIOBiotechnology
Healthcare
$0.80 +0.00%
+$0.00 today
- Market cap
- $56.44M
- Beta
- 1.29
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$0.32
52W Low $0.78High $3.82
Volume 0.43M
Average 0.81M
Balance Sheet
Inspect the capital base behind the business.
Assets
$99.11M
FY 2026 · Annual
+327.5% YoYLiabilities
$13.40M
FY 2026 · Annual
+61.3% YoYEquity
$85.71M
FY 2026 · Annual
+476.0% YoYBalance Sheet
USD
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 22.68M | 7.33M | 14.21M | 8.58M | 56.4M |
| Short-term Investments | 10.85M | 0 | 0 | 0 | 31.64M |
| Net Receivables | 6.1M | 204K | 713K | 105K | 1.1M |
| Inventory | 3.9M | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 18.73M | 749K | 1.03M | 3.08M |
| Total Current Assets | 45.07M | 26.26M | 15.67M | 9.72M | 92.22M |
| Property, Plant & Equipment (Net) | 41.76M | 7.55M | 6.37M | 5.28M | 4.75M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.85M | 5.39M | 5.37M | 6.85M | 1.83M |
| Long-term Investments | 7.63M | 1.96M | 1.3M | 1.31M | 228K |
| Tax Assets | (7.63M) | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 7.73M | 50K | 26K | 26K | 83K |
| Total Non-current Assets | 54.34M | 14.95M | 13.06M | 13.46M | 6.89M |
| Total Assets | 99.41M | 41.21M | 28.73M | 23.19M | 99.11M |
| Account Payables | 4.26M | 1.85M | 358K | 2.19M | 4.42M |
| Short-term Debt | 22.16M | 13.6M | 218K | 766K | 0 |
| Tax Payables | 284K | 268K | 0 | 0 | 0 |
| Deferred Revenue | 100K | 0 | 200K | 1.2M | 0 |
| Other Current Liabilities | 754K | 2.52M | 761K | 876K | 6.78M |
| Total Current Liabilities | 30.44M | 21.58M | 3.84M | 6.11M | 11.75M |
| Long-term Debt | 0 | 0 | 766K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.97M | 768K | 63K | 0 | 0 |
| Total Non-current Liabilities | 5.49M | 4.24M | 3.57M | 2.2M | 1.65M |
| Total Liabilities | 35.92M | 25.83M | 7.41M | 8.31M | 13.4M |
| Common Stock | 9K | 20K | 9K | 19K | 56K |
| Retained Earnings | (223.93M) | (288.94M) | (313.85M) | (332.22M) | (365.27M) |
| Accumulated OCI | (213K) | 0 | 0 | 0 | (45K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 63.49M | 15.38M | 21.32M | 14.88M | 85.71M |
| Total Debt | 25.77M | 17.07M | 4.46M | 3.51M | 2.2M |
| Net Debt | 3.09M | 9.75M | (9.75M) | (5.07M) | (54.2M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $56.4M |
| Short-term Investments | $31.6M |
| Receivables | $1.1M |
| Other Current | $3.1M |
| Total Current Assets | $92.2M |
| PP&E (Net) | $4.8M |
| Intangible Assets | $1.8M |
| Long-term Investments | $228.0K |
| Other Non-current | $83.0K |
| Total Non-current Assets | $6.9M |
| Total Assets | $99.1M |
Analysis
Selected assets total $99.1M for Latest. The largest visible component is Cash & Equivalents at $56.4M, about 56.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Oct 19, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 15, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 15, 2026 |
How much cash does IBIO have?
iBio, Inc. (IBIO) reported $56.40M in cash and equivalents in fiscal 2026.
How much debt does IBIO carry?
iBio, Inc. (IBIO) reported $2.20M of total debt, with net debt of -$54.20M.
Continue the stock analysis
Jump to another research area for this company.